Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Amphastar CC Notes:

Gary Jay Nachman, BMO Capital Markets Equity Research - Analyst [31]

Okay. And then just a couple of more, Jason. When do you expect to hear the court decision on the $100 million bond from the Momenta/Sandoz litigation? And then, Bill, just how will gross margins trend into the fourth quarter? Will it stay sort of at the same level that we just saw in the third quarter?

--------------------------------------------------------------------------------

Jason B. Shandell, Amphastar Pharmaceuticals, Inc. - President, General Counsel & Director [32]

So I'll start with the litigation, a good question. So first, we've been briefing, and the briefing actually was completed on October 25, a very precise issue regarding the inequitable conduct before the USP. So that was one of our equitable defenses. It's not regarding the invalidity. So that delayed the process. The briefing ended on October 25. So at this point, I'm predicting any time around Thanksgiving, but you never know with the court. But I believe we could see at any time, end of the year, early next year, a final judgment. That's the next step, they enter final judgment. We have not moved on the bond. We've been very conservative. We're waiting for the final judgment. Once the final judgment comes in, then we will move on the bond and also proceed with our antitrust case.